Cardiol Therapeutics (CRDL) Current Leases (2020 - 2026)
Cardiol Therapeutics (CRDL) posted Current Leases of $29016.6 for Q1 2026, up 5.52% on a QoQ basis from $27498.1 in Q4 2025, and up 21.56% year-over-year from $23870.8 in Q1 2025.
Cardiol Therapeutics (CRDL) Current Leases (2020 - 2026) Analysis & Trends
Cardiol Therapeutics' Current Leases history runs 7 years deep, the most recent figure standing at $29016.6 for Q1 2026.
- Quarterly Current Leases rose 21.56% year-over-year to $29016.6 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29016.6 (up 21.56% YoY) and the FY2025 annual result came in at $27498.1, up 16.37% from the prior year.
- Current Leases was $29016.6 for Q1 2026 at Cardiol Therapeutics, up from $27498.1 in the prior quarter.
- Across five years, Current Leases topped out at $38148.4 in Q1 2023 and bottomed at $11611.5 in Q4 2023.
- A 5-year average of $27340.8 and a median of $26831.0 in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases slumped 68.76% — and 2024, when it soared 103.5%.
- Cardiol Therapeutics' Current Leases stood at $37164.5 in 2022, then slumped by 68.76% to $11611.5 in 2023, then soared by 103.5% to $23629.5 in 2024, then rose by 16.37% to $27498.1 in 2025, then advanced by 5.52% to $29016.6 in 2026.
- Business Quant data shows CRDL's Current Leases at $29016.6 in Q1 2026, $27498.1 in Q4 2025, and $26831.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Cardiol Therapeutics | 134.05 Mn | 134.05 Mn | - | 29,016.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29,016.55 |
| Dec 31, 2025 | 27,498.11 |
| Sep 30, 2025 | 26,831.00 |
| Jun 30, 2025 | 25,661.21 |
| Mar 31, 2025 | 23,870.78 |
| Dec 31, 2024 | 23,629.46 |
| Sep 30, 2024 | 23,300.10 |
| Jun 30, 2024 | 15,879.64 |
| Mar 31, 2024 | 12,227.06 |
| Dec 31, 2023 | 11,611.54 |
| Sep 30, 2023 | 21,681.22 |
| Jun 30, 2023 | 35,878.14 |
| Mar 31, 2023 | 38,148.36 |
| Dec 31, 2022 | 37,164.45 |
| Sep 30, 2022 | 37,812.86 |
| Jun 30, 2022 | 37,813.06 |
| Mar 31, 2022 | 36,770.61 |
| Dec 31, 2021 | 35,468.47 |
| Sep 30, 2021 | 42,158.51 |
| Jun 30, 2021 | 42,468.56 |